Elequin Capital’s Livent Corporation LTHM Stock Holding History

Elequin Capital’s Portfolio LTHM Stock Details LTHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-90	Closed	-$1.62K	–	536
2023 Q4	$1.62K	Buy	+90	New	+$1.4K	﹤0.01%	295
2022 Q2	–	Sell	-53	Closed	-$1K	–	452
2022 Q1	$1K	Sell	53 -16	-23%	-$373	﹤0.01%	312
2021 Q4	$2K	Buy	+69	New	+$1.87K	﹤0.01%	37

Other funds holding LTHM

MIM

MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

MLICM

Metropolitan Life Insurance Company (MetLife) New York $328M AUM 9.77% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

ACA

American Capital Advisory Ketchum, Idaho $248M AUM 21.64% 1-Year Est. Return

Elequin Capital's LTHM Position: Q1 2024 in Review

Elequin Capital sold out of Livent Corporation (LTHM) in Q1 2024, closing a stake of 90 shares — an estimated $1.62K sold.

Elequin Capital first reported a position in LTHM in Q4 2021 and held it in 3 quarters. The position peaked at $2K in Q4 2021. 6 funds tracked by Wall St. Rank hold LTHM as of Q1 2024.

Elequin Capital reported no remaining Livent Corporation position as of Q1 2024 after selling out during the quarter.
Elequin Capital sold 90 Livent Corporation shares in Q1 2024, an estimated $1.62K.
Elequin Capital first reported a position in Livent Corporation in Q4 2021 and held it in 3 quarters.
Elequin Capital's Livent Corporation position peaked at $2K in Q4 2021.
6 funds tracked by Wall St. Rank held Livent Corporation as of Q1 2024.

Based on Elequin Capital's 13F filing for Q1 2024, filed 15 May 2024.